Elicio Therapeutics's three largest insider shareholders as of May 14, 2026 are Yekaterina Chudnovsky (Director, 5.42Mn shares), Llc Eisa-Abc (TenPercentOwner, 2.74Mn shares), Itzhak Goldberg (Director, 1.69Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Yekaterina Chudnovsky | - | 0 | 5,416,212 | 06 Mar, 2025 |
| Llc Eisa-Abc | - | 2,740,978 | 0 | 31 Aug, 2021 |
| Itzhak Goldberg | - | 1,687,986 | 0 | 11 Jul, 2022 |
| Robert Connelly | Ceo, President And Director | 120,570 | 0 | 03 Feb, 2026 |
| Christopher Haqq | - | 57,381 | 0 | 03 Feb, 2026 |
| John F. Neylan | - | 35,136 | 0 | 21 Dec, 2021 |
| Jennifer J Rhodes | - | 30,399 | 0 | 15 Dec, 2021 |
| Preetam Shah | - | 24,000 | 0 | 03 Feb, 2026 |
| Peter Demuth | Chief Scientific Officer | 21,543 | 0 | 03 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | Christopher Haqq | Common Stock | A | 25,400 | $0.00 | 57,381 | D | A |
| 02 Feb, 2026 | Peter Demuth | Common Stock | A | 20,800 | $0.00 | 21,543 | D | A |
| 02 Feb, 2026 | Robert Connelly | Common Stock | A | 73,600 | $0.00 | 120,570 | D | A |
| 02 Feb, 2026 | Preetam Shah | Common Stock | A | 24,000 | $0.00 | 24,000 | D | A |
| 02 Feb, 2026 | Preetam Shah | Stock Option (Right to Buy) | A | 47,900 | $0.00 | 47,900 | D | A |
| 02 Feb, 2026 | Robert Connelly | Stock Option (Right to Buy) | A | 147,200 | $0.00 | 147,200 | D | A |
| 02 Feb, 2026 | Christopher Haqq | Stock Option (Right to Buy) | A | 50,900 | $0.00 | 50,900 | D | A |
| 02 Feb, 2026 | Peter Demuth | Stock Option (Right to Buy) | A | 41,600 | $0.00 | 41,600 | D | A |
| 09 Dec, 2025 | Peter Demuth | Common Stock | A | 362 | $4.41 | 743 | D | M |
| 09 Dec, 2025 | Peter Demuth | Stock Option (Right to Buy) | D | 362 | $0.00 | 0 | D | M |
| 03 Jun, 2025 | Yekaterina Chudnovsky | Warrant (right to buy) | A | 103,225 | $0.00 | 103,225 | I | A |
| 19 May, 2025 | Karen J Wilson | Stock Option (Right to Buy) | A | 7,900 | $0.00 | 7,900 | D | A |
| 19 May, 2025 | Carol Gail Ashe | Stock Option (Right to Buy) | A | 7,900 | $0.00 | 7,900 | D | A |
| 19 May, 2025 | Yekaterina Chudnovsky | Stock Option (Right to Buy) | A | 7,900 | $0.00 | 7,900 | D | A |
| 19 May, 2025 | Julian Adams | Stock Option (Right to Buy) | A | 7,900 | $0.00 | 7,900 | D | A |
| 15 Apr, 2025 | Preetam Shah | Stock Option (Right to Buy) | A | 191,624 | $0.00 | 191,624 | D | A |
| 05 Mar, 2025 | Yekaterina Chudnovsky | Common Stock | A | 3,500,573 | $5.81 | 5,416,212 | I | C |
| 05 Mar, 2025 | Yekaterina Chudnovsky | Convertible Note (convertible into Common Stock) | D | 3,442,341 | $5.81 | 0 | I | C |
| 03 Feb, 2025 | Peter Demuth | Stock Option (Right to Buy) | A | 44,400 | $0.00 | 44,400 | D | A |
| 03 Feb, 2025 | Christopher Haqq | Stock Option (Right to Buy) | A | 44,000 | $0.00 | 44,000 | D | A |